Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination.
Vaccine
; 26(1): 59-66, 2007 Dec 21.
Article
em En
| MEDLINE
| ID: mdl-18063236
ABSTRACT
BACKGROUND:
Clinical trials of measles vaccination administered as aerosol are planned with the aim of obtaining licensure. Measles antibody levels will be measured using the plaque reduction neutralization test (PRNT) to assess antibody responses as a surrogate marker of efficacy.METHODS:
A working group examined laboratory protocols for measles PRNT in use at three reference centres and agreed to a standardised procedure, which was subsequently validated.RESULTS:
Assay validation showed quantitative results varied approximately threefold both within and between assays. The lower limit of detection was approximately 20milliInternational Units/mL.CONCLUSIONS:
A standardised laboratory protocol for measles PRNT was established and validated for use in clinical trials of aerosolized measles vaccines.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Testes de Neutralização
/
Vacina contra Sarampo
/
Anticorpos Antivirais
Tipo de estudo:
Guideline
Limite:
Animals
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article